720110login-checkLung Transplant Outcomes for COVID Respiratory Failure Similar to Other Etiologies |
— Survival, freedom from graft failure rates high, retrospective study finds
By Sophie Putka
Patients who received lung transplants due to irreversible respiratory failure from SARS-CoV-2 infection had similar outcomes to those who received lung transplants for other reasons, a retrospective study found.
Among 195 patients with COVID-19-related acute respiratory distress syndrome (ARDS) who underwent lung transplants, 1-, 6-, and 12-month overall survival rates were 99%, 95%, and 88%. For 190 patients who had COVID-19-related pulmonary fibrosis, survival rates were 96%, 92%, and 84%, respectively. Read the full article in MedPage Today.
720110login-checkLung Transplant Outcomes for COVID Respiratory Failure Similar to Other Etiologies |